Barile V, Kuzikov M, Cui W, Ianevski A, Iannelli F, Roca MS, Reinshagen J, Axelsson H, Leone A, Jenmalm Jensen A, Aittokallio T, Gribbon P, Seashore-Ludlow B, Budillon A(2026) Standardized workflow enables reproducibility of drug synergism detection: Results from a multi-center in vitro ring test on complex drug combinations in pancreatic cancer models Biomed Pharmacother, 200, 119575(in press) DOI 10.1016/j.biopha.2026.119575, PubMed 42224741
Willoch-Allen K, Zhao Z, Ayuda-Durán P, Mikaeloff F, Struyf N, Österroos A, Lehmann S, Kallioniemi O, Saarela J, Tyner JW, Erkers T, Enserink JM, Aittokallio T(2026) A multi-center study on the consistency of drug sensitivity testing in patients with acute myeloid leukemia NPJ Precis Oncol(in press) DOI 10.1038/s41698-026-01480-4, PubMed 42135420
Aung MMK, Schönefeldt S, Pfalz-Kraupp S, Wais T, Suske T, Zahma S, Franz S, Müllebner A, Feurstein G, Wagner C, Eder T, Pemovska T, Agreiter C, Pichler A, Staber PB, Hofer M, Steinborn R, Strohmer SV, Simonitsch-Klupp I, Bauer M, Wilfer A, Weber T, Potdar S, Aittokallio T, Jungherz Det al.(2026) Preclinical models of hepatosplenic γδ T-cell lymphoma with an activating STAT5B mutation display sensitivity to JAK inhibitor upadacitinib Hemasphere, 10(4), e70345 DOI 10.1002/hem3.70345, PubMed 42007450
